← Open Payments lookup

HEE SO: Open Payments

NPI 1215080270 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$397 in 23 payments from 11 companies in 2025. Trend: 2023 $193 · 2024 $479 · 2025 $397

Food & beverage: $397
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.6$96
Otsuka America Pharmaceutical, Inc.3$57
Neurocrine BioSciences, Inc.2$37
Axsome Therapeutics, Inc.2$36
Supernus Pharmaceuticals, Inc.2$36
ABBVIE INC.2$32
Tris Pharma Inc2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Bausch Health US, LLC1$19
Lundbeck LLC1$17

Products named: TRINTELLIX, REXULTI, INGREZZA, Auvelity, Qelbree, VRAYLAR, Dyanavel XR, CAPLYTA.

Industry payments across NJ — which companies pay providers there.